Australia, Feb. 24 -- Janssen Pharmaceutica NV, owns the trademark (2605475) for 'RYTOPTRI' till Nov. 3, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use.]
Type of Mark: Word
Date of Acceptance: Dec. 1, 2025
Registration Advertised: Feb. 23
For further details contact Actelion Pharmaceuticals Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2605475.
Disclaimer: Curated by HT Syndication.
